Prosecution Insights
Last updated: November 21, 2026

Garen Gotfredson, USPTO Patent Examiner

Listed by the USPTO as GOTFREDSON, GAREN

Tech Center 1600 • Art Units: 1615 1619 1626

This examiner grants 40% of resolved cases

Analysis

GOTFREDSON, GAREN is assigned to tech center 1600 and art unit 1615. The profile reports 550 resolved cases, a 39.8% allowance rate, and a median of 1418 days to allowance. Interview lift is 28.2%, positive and below the overall allowance measure.

The listed companies are Conopco, Inc. d/b/a Unilever, Novartis AG, and The Procter & Gamble Company. The listed firms are AMPACC Law Group, PLLC, BIRCH STEWART KOLASCH & BIRCH, LLP, and Byrne Poh LLP. The case volume supports meaningful examiner-level planning. Given the lower allowance result and extended median duration, counsel may benefit from early claim strategy and interview preparation, while maintaining alternatives for continued prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

39.8%
Allow Rate
-20.2% vs TC avg
612
Total Applications
+28.2%
Interview Lift
1418
Avg Prosecution Days
Based on 550 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
15.3%
§102 Novelty
40.8%
§103 Obviousness
21.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18261523 PHARMACEUTICAL COMPOSITION Final Rejection Novartis AG
18472478 HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR Final Rejection The Procter & Gamble Company
17126387 AZOXYSTROBIN EFFICACY IN PERSONAL CARE FORMS Final Rejection The Procter & Gamble Company
17621142 DEVICE FOR DELIVERING A FLOWABLE TISSUE DRESSING MATERIAL AND METHODS OF USE Final Rejection Solventum Intellectual Properties Company
18348787 DENSIFIED CO-PRECIPITATED MATERIALS ISOLATED BY THIN FILM EVAPORATION Final Rejection Merck Sharp & Dohme LLC
17768677 ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN Non-Final OA SYMRISE AG
17772897 SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA NANOSPHERES Non-Final OA ROHM AND HAAS COMPANY
18723269 SYNTHETIC BIOPOLYMERS AND THEIR USE IN COMPOSITIONS FOR TISSUE REPAIR Non-Final OA DSM IP ASSETS B.V.
18011643 ADJUVANTS Final Rejection GLAXOSMITHKLINE BIOLOGICALS SA
18571083 CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS Final Rejection RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
17642829 FLYING PEST CONTROL COMPOSITION AND FLYING PEST CONTROL SPRAY Non-Final OA Kao Corporation
18706245 HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS Final Rejection Conopco, Inc., d/b/a Unilever
17615222 PERSONAL CLEANSING COMPOSITIONS Final Rejection CONOPCO, INC.,D/B/A UNILEVER
18692081 POWDER COSMETIC Non-Final OA SHISEIDO COMPANY, LTD.
17611338 METHODS FOR ENCAPSULATION Final Rejection Chr. Hansen A/S
17768166 TARGETED BIFUNCTIONAL DEGRADERS Final Rejection YALE UNIVERSITY
17597703 MULTILAYER SHEET Final Rejection Eastman Chemical Company
17309195 Deodorant Compositions Final Rejection Colgate-Palmolive Company
18230227 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION Non-Final OA KEMIN INDUSTRIES, INC.
18176294 TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR Non-Final OA Incyte Corporation
17422346 IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS Final Rejection GIVAUDAN SA
18574435 AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD Non-Final OA NANJING HUASHI NEW MATERIAL CO., LTD
18214690 PERSONAL CARE DEODORANT PRODUCT VOID OF ENDOCRINE DISTRUPTING CHEMICALS Final Rejection thinkOperations, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Garen Gotfredson's allowance rate?

39.8% of resolved applications examined by Garen Gotfredson were allowed (550 resolved cases), compared with 43.8% across Art Unit 1615 over the last five years.

Does an interview help with examiner Garen Gotfredson?

This examiner's interview lift is +28.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Garen Gotfredson take to allow a patent?

Applications allowed by Garen Gotfredson took 1,418 days on average from filing to allowance.

Which art unit does examiner Garen Gotfredson work in?

Garen Gotfredson examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month